 (Jt Clin Pathol 1995;48:210-213) 
munoelectrophoresis.
Results-Eight of the 91 patients studied developed invasive aspergillosis. Positive latex agglutination tests were obtained in eight of 187 (4.3%) serum samples from four ofthese eight patients. The other four patients with invasive aspergillosis gave consistently negative latex agglutination tests. A positive latex agglutination test was the first indication of invasive aspergillosis in two patients; these patients were already on amphotericin B. Positive latex agglutination tests were the only evidence ofinvasive aspergillosis in one patient who subsequently died of the infection. False positive latex agglutination tests were obtained in five of 83 (6%) patients with no evidence ofinvasive aspergi1losis and misleading positive cultures seen in nine of 83 (10-8%) . No antibodies were detected in three of four liver transplant patients with invasive aspergillosis. Conversely, antibodies were detected in 63 of 262 (24%) serum samples from 43 liver transplant patients with no evidence of invasive aspergillosis; one of these patients had an antibody titre of 1:2 on four separate occasions.
Conclusions-The Pastorex aspergillus antigen latex agglutination test, when used alone, lacks sensitivity and specificity for the early diagnosis of invasive aspergillosis. A diagnosis was made in all patients with invasive aspergillosis when both culture and antigen tests were performed although using these criteria a false positive diagnosis would have been made in 13 Serum samples (n= 680) from patients undergoing bone marrow transplantation were tested with the latex agglutination reagent. Four patients had invasive aspergillosis confirmed at necropsy (cases 5 to 8; table 1). Four positive aspergillus antigen tests were obtained in 156 serum samples from these patients (2-6%; two were unconfirmed as there was insufficient specimen for repeat testing). All four positive tests were on serum samples from cases 5 and 6, and the aspergillus antigen test was the first indication of fungal infection in case 5, although positive agglutination was not confirmed. A fumigatus was isolated from BAL fluid from case 6 at nine weeks post-transplant, at which time antifungal chemotherapy with amphotericin B was instituted. Positive aspergillus antigen tests were not obtained on this patient until 22 weeks post-transplant, the last week of life.
Cases 7 and 8 did not give a positive antigen test despite 53 serum samples being screened. Case 7 had A fumigatus isolated from a nasal swab at six weeks post-transplant and died 24 weeks post-transplant. Case 8 developed a cerebral abscess from which A fumigatus was isolated at week 9 and died two weeks later.
Positive aspergillus antigen tests were also obtained on four other patients (cases 15 to 18), although they had no mycological, radiological or clinical evidence of invasive aspergillosis (table 2) . Two of these patients remain well, 27 and 11 months after transplantation, despite receiving no antifungal therapy. One patient died but had no evidence of invasive aspergillosis at necropsy and one patient received amphotericin B on the basis of the antigen result and was well at the time of writing.
Thirty six patients (439 serum samples) had negative antigen test results. A fumigatus was recovered from specimens from three of these patients (table 2) 
Discussion
Reliable diagnosis of invasive aspergillosis is difficult and is often only made at necropsy. Aspergillus is only recovered from sputum in 8-34% of patients and sputum samples are often scanty or unavailable.8 In some cases recovery of Aspergillus from sputum may be because of contamination rather than infection; culture of BAL fluid or tracheal aspirate specimens may give more accurate results. In our series of patients A fumigatus was isolated from respiratory specimens (nasal swab, sputum, BAL fluid, tracheal aspirate) from five of the eight (62%) patients with invasive aspergillosis but also from six of 83 (7-2%) patients with no evidence of invasive aspergillosis.
Antibody detection lacked both sensitivity and specificity. Only one of our liver transplant patients with confirmed invasive aspergillosis had detectable antibodies to A fumigatus whereas antibody tests were positive in 20 of 42 patients with no evidence of invasive aspergillosis; one of these latter patients had an antibody titre of 1:2 on at least four occasions. It is unlikely that the presence of antibodies to Aspergillus affected antigen detection as heat treatment of serum before testing with the latex agglutination reagent would dissociate any immune complexes.
In this prospective study the latex agglutination aspergillus antigen detection test lacked sufficient sensitivity for the early diagnosis of invasive aspergillosis, which would influence treatment, but was of value in helping to confirm a diagnosis. The antigen test was positive in four of the eight (50%) patients with invasive aspergillosis and was the first indicator of infection in two patients; all of the patients with invasive aspergillosis in this study, however, had been receiving empirical antifungal chemotherapy with amphotericin B for several days before confirmation of infection by either culture or antigen testing. Two positive latex agglutination tests were the only evidence of invasive aspergillosis in a bone marrow transplant recipient who subsequently died of the infection.
Confirmed false positive latex agglutination tests were obtained in five of 83 (6%) cases. The reasons for these false positive antigen tests are not known although it has been suggested that contamination of serum samples with some airborne moulds,9 or bacteria,'0 may result in cross-reactivity with the monoclonal antibody used in the kit. Care was taken with other factors which may interfere with the test"; all serum samples were separated from the clot well within 24 hours of sampling, microcentrifuge tubes were properly sealed during boiling and, as the volumes of reagents were halved, the serum-latex mixtures were covered during mixing to prevent dessication.
Antigen detection tests for the diagnosis of invasive aspergillosis can give more meaningful results by testing sequential rather than single serum samples.4 However, in this study, four patients with invasive aspergillosis gave consistently negative antigen test results despite testing multiple samples.
The diagnosis of invasive aspergillosis was enhanced when antigen tests and culture were both performed; a positive culture and/or antigen test occurred in all eight patients with invasive aspergillosis. However, using these criteria a false positive diagnosis would also have been made in 16% (13/83) of patients with no clinical or radiological evidence of invasive aspergillosis.
Clearly, methods for the diagnosis of invasive aspergillosis still need to be improved. Urine'2 and BAL fluid'3 have both been shown to contain detectable antigen in patients with invasive aspergillosis and these may be better specimens to test than serum. Unfortunately, the latex agglutination reagent evaluated in this study is only suitable for use on serum samples. Until more reliable tests such as the polymerase chain reaction are developed for the diagnosis of invasive aspergillosis, the Pastorex aspergillus antigen latex agglutination test alone should not be relied on to give an early diagnosis of invasive aspergillosis and users of the test should recognise its limitations and interpret its results with care.
Despite the disappointing performance of this latex agglutination test, we still believe that both microbiological and serial serological investigations for aspergillus antigen should be performed to maximise the chances of diagnosing invasive aspergillosis and the results considered in conjunction with radiological and clinical evidence of infection.
